Screening for cancer of the colon and rectum A review on incidence, mortality, cost and benefit

Abstract

Key words: Colorectal cancer, Screening, Incidence, Mortality, Cost-effectiveness In this article the incidence and mortality for cancer of the colon and rectum in Iceland is discussed. The two most common screening methods, faecal immunochemical test (FIT) and colonoscopy are compared and an estimate of cost and benefits for the Icelandic society will be made. The incidence of cancer of the colon and rectum has been increasing in Iceland in last decades but mortality has decreased and survival improved. However, more individuals die from cancer of the colon and rectum than from both breast- and cervical cancer added together. It is likely that screening for cancer of the colon and rectum, could prevent at least 6 of the 28 deaths related to those cancers, occurring yearly in Iceland in screening age, given a screening ages of 50-74 years. The extra cost for the Icelandic community due to the implementation of screening for cancer of the colon and rectum will be acceptable due to the lower cost of simpler treatments, lower cancer incidence and reduced mortality.

Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis

“…OS between patients with or without a pregnancy after BC was reported in 21 studies. 25-29,32,34-37,40,41,43-45,48,54,58,60,61,63…”

Comprehensive Analysis of the Expression, Prognostic Value, and Immune Infiltration Activities of GABRD in Colon Adenocarcinoma

“…It is believed that a number of different causes are responsible for this variation in occurrence [ 4 , 5 ]. To be more specific, among other things, socioeconomic status is important, with a poor socioeconomic level being related to an increased risk of developing COAD [ 6 , 7 ]. The death rate associated with COAD has declined by around 35% from 1990 to 2007, and it is presently down approximately 50% from its highest mortality rate.…”

ALDH2 gene rs671 G > a polymorphism and the risk of colorectal cancer: A hospital‐based study

“…Colorectal cancer (CRC) is a cancer that occurs in the colon or rectum and can occur in any part of the colon, with the rectum and sigmoid colon being the most common. 1 According to the latest global cancer statistics, the incidence (19.5 people per 100,000 people) and mortality (9.0 people per 100,000 people) of CRC rank third and second, respectively. 2 In China, the incidence of CRC increased rapidly, and the incidence and mortality of CRC rank second and fifth, respectively.…”

“…This study cohort consisted of 178 CRC patients and 261 controls from Meizhou People's Hospital, China, between January 2016 and December 2020. The inclusion criteria of patients were:(1) patients diagnosed with histologically confirmed colorectal cancer;(2) patients without other tumors and serious infectious diseases;(3) patients without missing information; (4) ≥18 years old. The inclusion criteria of controls were: (1) from the physical examination Center of Meizhou People's Hospital and did not develop CRC until 2020; (2) had no history of other tumors of the digestive system or end-stage kidney diseases; (3) ≥18 years old.…”